Gilead Sciences Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (407)

Latest Posts

About This Stock More About This Stock
4 Biotech Stocks To Add To Your Portfolio Post Q2 Earnings
Article By: Arpita Dutt
Tuesday, August 22, 2017 12:02 PM EDT
The second half of 2017 is expected to be catalyst rich for quite a few companies with data expected across a wide range of therapeutics areas.
In this article: ALXN, GILD, REGN, LGND Also: AMGN, NVS
Read
10 Undervalued Stocks For The Enterprising Investor – August 2017
Article By: Benjamin Clark
Sunday, August 20, 2017 5:01 PM EDT
Using the ModernGraham Valuation Model, I’ve selected the ten most undervalued companies. Each company has been determined to be suitable for the Enterprising Investor.
In this article: AHL, FL, KBH, KORS, LYB, SIG, GILD, NAVI, LNR, LUC
Read
Investors Expecting Growth From Large Caps And M&A From Mid-Caps
Article By: Rod Raynovich
Tuesday, August 15, 2017 9:37 PM EDT
Biotech stocks in general have recovered from last week’s sell-off and remain in a monthly trend up despite a topping pattern from July. Despite weak seasonality and lack of M&A the sector is holding lows with good volume.
In this article: BMY, IBB, AMGN, CELG, GILD, XBI, XLV, ABBV, BLUE, FMI
Read
5 Undervalued Large Cap Stocks For Value Investors – August 2017
Article By: Benjamin Clark
Tuesday, August 15, 2017 12:09 AM EDT
There are a number of great companies in the market today. By using the ModernGraham valuation model, I’ve screened the 830+ companies to select five large-cap undervalued companies for value investors.
In this article: KR, LNC, LYB, GILD, SYF
Read
Forget Teva, Buy These 4 Drug Stocks Instead
Article By: Arpita Dutt
Friday, August 11, 2017 1:17 PM EDT
It’s not been a good quarter for Israel-based generic drug maker, Teva Pharmaceutical Industries Limited. Teva missed on both second quarter earnings and revenues and lowered its outlook for 2017.
In this article: SNY, ALXN, REGN, GILD, TEVA
Read

PARTNER HEADLINES

Latest Tweets for $GILD

No tweets yet!

$GILD

Gilead Crohn's Treatment Is Not The Solution To GLD Revenue Issues
Kurt Benson 3/24/2017 10:12:59 PM

I have to agree with your assessment on $GILD. Do you know anything about $VBIO? I read a promising article here about their having a major breakthrough in #Crohn's research.

www.talkmarkets.com/.../interview-with-vitality-biopharma-inc

Not a lot of info on the company though.

Gilead Crohn's Treatment Is Not The Solution To GLD Revenue Issues
Kirk Sheffield 3/24/2017 10:11:55 PM

I think $GILD will rebound. This isn't the only product they have in their pipeline.

Gilead Crohn's Treatment Is Not The Solution To GLD Revenue Issues
Alpha Stockman 3/24/2017 10:07:45 PM

I've been rather disappointed with #Gilead myself. After reading your article, I'm planning to offload some $GILD.

Gilead Sciences Receives Canadian Approval For HIV Drug
David Reynolds 2/20/2017 10:04:11 PM

The opening up of this market for #GileadSciences should bode well for the stock $GILD.

Gilead Sciences: Cheap Growth Or Value Trap?
Karen Klein 9/13/2016 5:39:48 PM

Excellent analysis, you have effectively convinced me to change my position on #Gilead. $GILD

3 Cult Stocks To Avoid In 2015
Bruce Powers 1/26/2015 8:01:06 AM

Great article and glad to read the reasoning to consider $GILD as a safer investment short, mid and long term.

3 Cult Stocks To Avoid In 2015
BreakingBad News 1/25/2015 6:09:51 PM

Sorry all, thanks for the clarification. My bad! Now that I've read it through, it all makes total sense. $GILD, $BAC, $WFM, and $VA are my plays for 2015.

3 Cult Stocks To Avoid In 2015
BreakingBad News 1/25/2015 4:48:08 PM

I'd say this is a minority view, I've seen several others stating that $GILD was a stock to buy this year.

1 to 8 of 8 comments